Waldman F - Search Results

1

Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.

Wang G, Black PC, Goebell PJ, Ji L, Cordon-Cardo C, Schmitz-Dräger B, Hawes D, Czerniak B, Minner S, Sauter G, Waldman F, Groshen S, Cote RJ, Dinney CP. Wang G, et al. Among authors: waldman f. Urol Oncol. 2021 May;39(5):301.e17-301.e28. doi: 10.1016/j.urolonc.2021.01.021. Epub 2021 Feb 7. Urol Oncol. 2021. PMID: 33563539 Free PMC article.

2

Generation of a concise gene panel for outcome prediction in urinary bladder cancer.

Mitra AP, Pagliarulo V, Yang D, Waldman FM, Datar RH, Skinner DG, Groshen S, Cote RJ. Mitra AP, et al. J Clin Oncol. 2009 Aug 20;27(24):3929-37. doi: 10.1200/JCO.2008.18.5744. Epub 2009 Jul 20. J Clin Oncol. 2009. PMID: 19620494 Free PMC article.

3

Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study.

Grossman HB, Tangen CM, Cordon-Cardo C, Cote R, Waldman FM, De Vere White RW, Karnad AB, Glode M, Crawford ED. Grossman HB, et al. Oncol Rep. 2006 Oct;16(4):807-10. Oncol Rep. 2006. PMID: 16969498 Clinical Trial.

4

Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder.

Cheng J, Huang H, Pak J, Shapiro E, Sun TT, Cordon-Cardo C, Waldman FM, Wu XR. Cheng J, et al. Cancer Res. 2003 Jan 1;63(1):179-85. Cancer Res. 2003. PMID: 12517796

5

LM-PCR permits highly representative whole genome amplification of DNA isolated from small number of cells and paraffin-embedded tumor tissue sections.

Liu D, Liu C, DeVries S, Waldman F, Cote RJ, Datar RH. Liu D, et al. Among authors: waldman f. Diagn Mol Pathol. 2004 Jun;13(2):105-15. doi: 10.1097/00019606-200406000-00007. Diagn Mol Pathol. 2004. PMID: 15167012

6

Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.

Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. Veltman JA, et al. Cancer Res. 2003 Jun 1;63(11):2872-80. Cancer Res. 2003. PMID: 12782593

7

Bladder cancer outcome and subtype classification by gene expression.

Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM. Blaveri E, et al. Among authors: waldman fm. Clin Cancer Res. 2005 Jun 1;11(11):4044-55. doi: 10.1158/1078-0432.CCR-04-2409. Clin Cancer Res. 2005. PMID: 15930339

8

CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells.

Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, Carroll P, Simko J, Waldman FM, Basbaum C. Retz MM, et al. Int J Cancer. 2005 Mar 20;114(2):182-9. doi: 10.1002/ijc.20729. Int J Cancer. 2005. PMID: 15540205

9

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM. Blaveri E, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7012-22. doi: 10.1158/1078-0432.CCR-05-0177. Clin Cancer Res. 2005. PMID: 16203795

10

FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.

Lal A, Chan L, Devries S, Chin K, Scott GK, Benz CC, Chen YY, Waldman FM, Hwang ES. Lal A, et al. Among authors: waldman fm. Breast Cancer Res Treat. 2013 Jun;139(2):381-90. doi: 10.1007/s10549-013-2556-4. Epub 2013 May 28. Breast Cancer Res Treat. 2013. PMID: 23712790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page